TAL2 (TAL bHLH transcription factor 2) is a basic helix-loop-helix (bHLH) transcription factor that plays critical roles in hematopoietic cell development and neuronal differentiation. The protein functions as a DNA-binding transcription factor that requires heterodimerization with E2A proteins (E47 and E12) to bind DNA in a sequence-specific manner, as TAL2 cannot bind DNA alone 1. TAL2 belongs to a family of related bHLH proteins including TAL1 and LYL1, each implicated in T-cell acute lymphoblastic leukemia (T-ALL) development 2. The gene is activated by the t(7;9)(q34;q32) chr9 translocation in approximately 25% of T-ALL patients, where it becomes juxtaposed with T-cell receptor beta-chain sequences 3. Beyond its oncogenic role, TAL2 functions in normal development, particularly in midbrain GABAergic neuron differentiation where it cooperates with Tal1 and works downstream of Gata2 4. The protein is also expressed in myeloid lineage cells and is upregulated during osteoclastogenesis as a direct target of PU.1 transcription factor 5. TAL2 undergoes post-translational phosphorylation, particularly at serine residue 100 by MAP kinases, existing in both phosphorylated and unphosphorylated forms 1. Recent studies have identified pathogenic mutations in TAL2 in B-lineage ALL patients, suggesting broader roles in hematopoietic malignancies 6.